Let AI watch the worldβs key changes for you unkAI
unkAI continuously tracks the public intelligence and global changes you care about, and only alerts you when noteworthy new developments emerge. Subscribe for free by email β no repeated interruptions, no missed key changes.
Health
44 items Β· Recommended
Expansion of clinical application of the global innovative hypertension drug baxdrostat
Follow up on clinical application data, indication expansion applications, pharmaceutical company capacity supply and global marketing dynamics after FDA approves baxdrostat for marketing.
U.S. FDA Innovative Drug Approval Milestones for the Second Half of 2026
Follow up on the review progress, approval results, and new indication expansions of new molecular entity drugs pending FDA review in the second half of the year, and update the annual approved drug list.
Global Research and Development and Clinical Trends of Opioid-Free Analgesics
Track the R&D pipeline of targeted sodium channel opioid-free analgesics, follow up on clinical stage advancement, clinical trial data, pharmaceutical company cooperation and changes in regulatory review nodes.
U.S. FDA approval timeline for Novo Nordisk's CagriSema
Follow the FDA review progress of Novo Nordisk's combination weight loss drug CagriSema, track the PDUFA date, approval result and approved indication scope.
Dynamics of clinical application of shoulder arthroplasty surgical robots in China
Observing changes in marketing approval, clinical application effects and promotion scope of China's first shoulder arthroplasty surgical robot system
Changes in market supply of Chinese drugs removed from medical insurance after the transition period
Follow up on changes in market supply, price adjustment and patient accessibility of 8 drugs removed from the medical insurance catalog after the transition period ends.
Dynamics of the implementation of Chinese herbal medicine insert specification in China
Follow up on the implementation of the Special Provisions on Traditional Chinese Medicine Registration after three years, and observe the rectification of unclear content and changes in re-registration results.
R&D and commercialization dynamics of personalized mRNA tumor vaccines
Track the progress of clinical trials, regulatory approval, indication expansion, mass production and commercial launch of personalized mRNA tumor vaccines.
Implementation dynamics of China's regulations on protecting the rights and interests of over-aged workers
Observe changes in employers' compliance adjustments and disputes over the implementation of rights protection after the implementation of the Interim Provisions on the Protection of Basic Rights and Interests of Over-aged Workers.
Progress of rapid review of cell and gene therapy medicines in China
Follow up on changes in the approval progress of eligible cell and gene therapy medicines after the drug regulatory authority opened the rapid review channel for innovative drugs.
Global Commercialization Progress of Precision Cell Therapy
To observe the clinical application, pricing strategy, market penetration and iteration of industrial technology routes after the approval of precision cell therapies such as Orca-T.
New drug approval dynamics of China's National Medical Products Administration
Follow up the weekly new drug approval results of China's National Medical Products Administration, and focus on the approval dynamics and market impact in innovative drugs, anti-tumor drugs, medical devices and other fields.